Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
Journal of Psychiatry and Neuroscience June 1, 2022 Stephanie L. Borgland, Drew M. Neyens 14 citations
Private clinics and registered clinical trials using serotonergic psychedelics for psychiatric conditions such as substance use disorder and major depressive disorder have grown substantially. Classical psychedelics include lysergic acid diethylamide.